Enhance Decision-Making When Prescribing Medications for Psychiatric Conditions

  • Treatment decisions guided by genetic test results can offer a personalized and more precise treatment plan.

  • Less than 1/3 of depressed patients respond to their initial antidepressant.¹

  • The genes analyzed in the MyPGt™ test are associated with a wide range of medications and can help to inform treatment plans for psychiatric illnesses.

  • Order the MyPGt™ panel for mental health patients.

 
 
 

MyPGt™ Genotype Report Helps You:

•Minimize the trial and error method of drug therapy

•Reduce adverse drug reactions

•Improve patient care

 

References:
¹Rush JA et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006; Mar 23:354(12):1231-42. https://www.ncbi.nlm.nih.gov/pubmed/16554525